07.22.24 -- Optimizing Clinical Research: Tech, Teamwork, And Trial Strategies

Frank Baitman, a leader in digital health, data, and technology, and former Chief Information Officer of the U.S. Department of Health and Human Services discusses why multidisciplinary collaboration is crucial for advancing research and innovation in health and life sciences.

Site selection remains manual and error-prone, leading to poor enrollment and increased costs. To mitigate these issues, learn how a strategic approach to site selection can enhance resource productivity, reduce costs, and improve the success of clinical trials.

Concomitant medications (con-meds) significantly influence clinical trials, including prescription drugs, over-the-counter remedies, and supplements taken with the investigational drug. They affect trial duration, costs, participant eligibility, and safety. Despite their importance, con-meds often evade thorough tracking and analysis in clinical studies.